The underrepresentation of minorities in basic, clinical, and behavioral research has been viewed as a significant barrier to addressing cancer disparities and the inclusion of minority populations in clinical trials. Thus, there is a need to develop a cadre of racially and ethnically diverse, well-trained scientists. In this application, w will address the following barriers that underrepresented minorities (URMs) face with a comprehensive, rigorous, and innovative approach that will create opportunities and promote careers in cancer research for these researchers and students: (1) the lack of committed role models, (2) inadequate mentoring, (3) insufficient preparation, (4) low expectations, and (5) unfamiliarity with the culture and idioms of science. Our application focuses on developing a Florida Minority Cancer Research &Training (MiCaRT) Center that will expand our cancer research and training opportunities for URM faculty and students at UF and FAMU and ultimately grow the number of URM scientists and clinical investigators in biomedical research. The University of Florida (UF)-Florida A&M University (FAMU) MiCaRT Center will build on our existing cancer research and training opportunities to grow the number of URM scientists and clinical investigators in higher education and academic leadership. The combination of research training and career development plans for program participants will also create a hub of cancer disparity research activities at both UF and FAMU. Program success will be measured by: (1) admission of students to graduate or medical school for oncology-related training;(2) peer-reviewed presentations;(3) peer-reviewed publications;and (4) extramural NIH/NCI grant submissions.
The primary objective of this University of Florida (UF)-Florida A&M University (FAMU) P20 application is to develop a Florida Minority Cancer Research &Training (MiCaRT) Center that will expand our oncology research and training opportunities for underrepresented minority researchers and students and ultimately grow the number of underrepresented scientists and clinical investigators in higher education and academic leadership.
|Scarton, Lisa; Yoon, Saunjoo; Oh, Sungho et al. (2018) Pancreatic Cancer Related Health Disparities: A Commentary. Cancers (Basel) 10:|
|Odedina, Folakemi T; Reams, R R; Kaninjing, E et al. (2018) Increasing the Representation of Minority Students in the Biomedical Workforce: the ReTOOL Program. J Cancer Educ :|
|Morrison, Belinda F; Aiken, William D; Mayhew, Richard et al. (2017) Prostate Cancer Knowledge, Prevention, and Screening Behaviors in Jamaican Men. J Cancer Educ 32:352-356|
|Morozov, Viacheslav M; Li, Ying; Clowers, Matthew M et al. (2017) Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer. Oncotarget 8:62131-62142|
|Nguyen, Jennifer; Moorhouse, Michael; Curbow, Barbara et al. (2016) Construct Validity of the eHealth Literacy Scale (eHEALS) Among Two Adult Populations: A Rasch Analysis. JMIR Public Health Surveill 2:e24|
|Mochona, Bereket; Qi, Xin; Euynni, Suresh et al. (2016) Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents. Bioorg Med Chem Lett 26:2847-2851|
|Black, Joseph B; Premont, Richard T; Daaka, Yehia (2016) Feedback regulation of G protein-coupled receptor signaling by GRKs and arrestins. Semin Cell Dev Biol 50:95-104|